Dilworth IP Partner Appointed to CURE’s Board of Directors
Dr. Anthony Sabatelli, Partner and Chair of Dilworth IP’s Biotech and Pharmaceutical IP practice group, has been appointed to serve on CURE’s Board of Directors. CURE (Connecticut United for Research Excellence) serves as the bioscience cluster for the state, and is a diverse community of small and large life and healthcare sciences companies, ranging in scope from therapeutics, to healthcare technology, to medical devices. Universities, government agencies, scientists, educators, mentors, students, entrepreneurs, business experts, service providers and investors further form the breadth of the network. Regarding his appointment, Dr. Sabatelli said that “I am honored to serve CURE in this capacity because it is an important advocate for the state’s bioscience community.”
Dr. Sabatelli’s CURE bio can be found here.
Dilworth IP is an intellectual property and business law firm providing legal services in the areas of patent and trademark prosecution, opinions and agreements in the chemical, biotech, pharmaceutical, medical device, material science, consumer products, electronics, software, and semiconductor industries. We’ve been in the lab. Whether your invention is a controlled-release pharmaceutical, a fuel cell, or a new circuit schematic, our attorneys will speak your language and listen well. We’ll quickly grasp nuances of your complex technology and capture the IP protection you deserve. To learn more about the firm, please visit www.dilworthip.com.